309 related articles for article (PubMed ID: 22232070)
41. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
[TBL] [Abstract][Full Text] [Related]
42. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
43. Yap1 is dispensable for self-renewal but required for proper differentiation of mouse embryonic stem (ES) cells.
Chung H; Lee BK; Uprety N; Shen W; Lee J; Kim J
EMBO Rep; 2016 Apr; 17(4):519-29. PubMed ID: 26917425
[TBL] [Abstract][Full Text] [Related]
44. The Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase Regulators of the Hippo Signaling Pathway.
Mui MZ; Zhou Y; Blanchette P; Chughtai N; Knight JF; Gruosso T; Papadakis AI; Huang S; Park M; Gingras AC; Branton PE
J Virol; 2015 Sep; 89(17):8855-70. PubMed ID: 26085163
[TBL] [Abstract][Full Text] [Related]
45. Upregulation of miR-130b enhances stem cell-like phenotype in glioblastoma by inactivating the Hippo signaling pathway.
Zhu G; Wang Y; Mijiti M; Wang Z; Wu PF; Jiafu D
Biochem Biophys Res Commun; 2015 Sep; 465(2):194-9. PubMed ID: 26241672
[TBL] [Abstract][Full Text] [Related]
46. Opposite regulation of Wnt/β-catenin and Shh signaling pathways by Rack1 controls mammalian cerebellar development.
Yang H; Zhu Q; Cheng J; Wu Y; Fan M; Zhang J; Wu H
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4661-4670. PubMed ID: 30765517
[TBL] [Abstract][Full Text] [Related]
47. Direct inhibition of the NOTCH transcription factor complex.
Moellering RE; Cornejo M; Davis TN; Del Bianco C; Aster JC; Blacklow SC; Kung AL; Gilliland DG; Verdine GL; Bradner JE
Nature; 2009 Nov; 462(7270):182-8. PubMed ID: 19907488
[TBL] [Abstract][Full Text] [Related]
48. αE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.
Li P; Silvis MR; Honaker Y; Lien WH; Arron ST; Vasioukhin V
Genes Dev; 2016 Apr; 30(7):798-811. PubMed ID: 27013234
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
[TBL] [Abstract][Full Text] [Related]
50. TEAD1 mediates the oncogenic activities of Hippo-YAP1 signaling in osteosarcoma.
Chai J; Xu S; Guo F
Biochem Biophys Res Commun; 2017 Jun; 488(2):297-302. PubMed ID: 28483529
[TBL] [Abstract][Full Text] [Related]
51. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon.
Coant N; Ben Mkaddem S; Pedruzzi E; Guichard C; Tréton X; Ducroc R; Freund JN; Cazals-Hatem D; Bouhnik Y; Woerther PL; Skurnik D; Grodet A; Fay M; Biard D; Lesuffleur T; Deffert C; Moreau R; Groyer A; Krause KH; Daniel F; Ogier-Denis E
Mol Cell Biol; 2010 Jun; 30(11):2636-50. PubMed ID: 20351171
[TBL] [Abstract][Full Text] [Related]
52. YAP and TAZ Take Center Stage in Cancer.
Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W
Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056
[TBL] [Abstract][Full Text] [Related]
53. Aberrant activation of canonical Notch1 signaling in the mouse uterus decreases progesterone receptor by hypermethylation and leads to infertility.
Su RW; Strug MR; Jeong JW; Miele L; Fazleabas AT
Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2300-5. PubMed ID: 26858409
[TBL] [Abstract][Full Text] [Related]
54. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.
Ehmer U; Sage J
Mol Cancer Res; 2016 Feb; 14(2):127-40. PubMed ID: 26432795
[TBL] [Abstract][Full Text] [Related]
55. Integrated Analyses Reveal Overexpressed Notch1 Promoting Porcine Satellite Cells' Proliferation through Regulating the Cell Cycle.
Jiao Y; Huang B; Chen Y; Hong G; Xu J; Hu C; Wang C
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337929
[TBL] [Abstract][Full Text] [Related]
56. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
[TBL] [Abstract][Full Text] [Related]
57. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers.
Kang W; Cheng AS; Yu J; To KF
World J Gastroenterol; 2016 Jan; 22(3):1279-88. PubMed ID: 26811664
[TBL] [Abstract][Full Text] [Related]
58. Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.
Serinagaoglu Y; Paré J; Giovannini M; Cao X
Dev Biol; 2015 Feb; 398(1):97-109. PubMed ID: 25433207
[TBL] [Abstract][Full Text] [Related]
59. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.
Pan Y; Tong JHM; Lung RWM; Kang W; Kwan JSH; Chak WP; Tin KY; Chung LY; Wu F; Ng SSM; Mak TWC; Yu J; Lo KW; Chan AWH; To KF
Mol Cancer; 2018 Jul; 17(1):102. PubMed ID: 30037330
[TBL] [Abstract][Full Text] [Related]
60. Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells.
VanDussen KL; Carulli AJ; Keeley TM; Patel SR; Puthoff BJ; Magness ST; Tran IT; Maillard I; Siebel C; Kolterud Å; Grosse AS; Gumucio DL; Ernst SA; Tsai YH; Dempsey PJ; Samuelson LC
Development; 2012 Feb; 139(3):488-97. PubMed ID: 22190634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
